Advantages and Disadvantages of Increasing Pharmaceutical R&D Outsourcing to India and China

Advantages and Disadvantages of Increasing Pharmaceutical R&D Outsourcing to India and China

 

RELEASE DATE
22-Jul-2005
REGION
Europe
Research Code: B600-01-00-00-00
SKU: HC01104-EU-MR_05163
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC01104-EU-MR_05163

$4,950.00

$3,712.50save 25 %

DownloadLink
ENQUIRE NOW

Description

The objective of this research service is to provide detailed analysis of Pharmaceutical R&D outsourcing to India and China.

Table of Contents

Executive Summary

  • Summary of Advantages and Disadvantages of Increasing Pharmaceutical R&D Outsourcing to India and China

R&D Outsourcing to India

Market Engineering Research

  • Indian Industry Landscape
  • Clinical Trials in India - Regulations
  • SWOT Analysis
  • Key Trends

CRO Profiles

  • Key Market Engineering Measurements
  • Outsourced Clinical Research Market Forecasts

Pharmaceutical Company Profiles

  • Contract Research Organisations

Strategic Anticipation

Potential Threats

Opportunities Clinical Research to India and China

Related Research
The objective of this research service is to provide detailed analysis of Pharmaceutical R&D outsourcing to India and China.
More Information
No Index No
Podcast No
Industries Healthcare
WIP Number B600-01-00-00-00
Is Prebook No